history of glp-1 agonists Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Market Overview: GLP-1 Agonists and

So when someone says, GLP-1s cause muscle loss, the first question should be: what exactly was measured

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

Evidence-based insights for patients and providers.

Although most of the studies reported an association between GLP-1 RA and increased residual gastric contents, evidence linking these medications to a statistically significant rise in regurgitation or aspiration events remains highly inconsistent

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

The heatmap below illustrates how side effects differ across GLP-1 drugs, offering a snapshot of how people experience their GLP-1 medication in everyday life